In a humanized mouse model bearing human PD-L1-expressing tumors, HK010 displayed superior efficacy in eradicating established tumors even when the dose was as low as 0.3 mg/kg, and could induce durable antigen-specific immune memory to prevent rechallenged tumor growth. The gene discussed is CD274; the disease is neoplasm.